SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.
Revenue is primarily driven by Collaboration (100%).
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Revenue by Segment
No significant events in the past 90 days.